Skip Navigation
Skip to contents

Yonsei Med J.  2017 Mar;58(2):339-346. 10.3349/ymj.2017.58.2.339.

Impact of Serum Leptin to Adiponectin Ratio on Regression of Metabolic Syndrome in High-Risk Individuals: The ARIRANG Study

Affiliations
  • 1Department of Humanities and Social Medicine, Ajou University School of Medicine, Suwon, Korea.
  • 2Department of Preventive Medicin, Yonsei University Wonju College of Medicine, Wonju, Korea. dodge@yonsei.ac.kr
  • 3Institute of Genomic Cohort, Yonsei University, Wonju, Korea.
  • 4Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea.

Abstract

PURPOSE
The ratio of serum leptin to adiponectin (L/A ratio) could be used as a marker for insulin resistance. However, few prospective studies have investigated the impact of L/A ratio on improvement of metabolic components in high-risk individuals with metabolic syndrome. We examined the association between L/A ratio and the regression of metabolic syndrome in a population-based longitudinal study.
MATERIALS AND METHODS
A total of 1017 subjects (431 men and 586 women) with metabolic syndrome at baseline (2005-2008) were examined and followed (2008-2011). Baseline serum levels of leptin and adiponectin were analyzed by radioimmunoassay. Area under the receiver operating characteristics curve (AUROC) analyses were used to assess the predictive ability of L/A ratio for the regression of metabolic syndrome.
RESULTS
During an average of 2.8 years of follow-up, metabolic syndrome disappeared in 142 men (32.9%) and 196 women (33.4%). After multivariable adjustment, the odds ratios (95% confidence interval) for regression of metabolic syndrome in comparisons of the lowest to the highest tertiles of L/A ratio were 1.84 (1.02-3.31) in men and 2.32 (1.37-3.91) in women. In AUROC analyses, L/A ratio had a greater predictive power than serum adiponectin for the regression of metabolic syndrome in both men (p=0.024) and women (p=0.019).
CONCLUSION
Low L/A ratio is a predictor for the regression of metabolic syndrome. The L/A ratio could be a useful clinical marker for management of high-risk individuals with metabolic syndrome.

Keyword

Leptin; adiponectin; metabolic syndrome; insulin resistance; prospective study

MeSH Terms

Adiponectin/*blood
Adult
Biomarkers/blood
Female
Humans
Insulin Resistance
Leptin/*blood
Longitudinal Studies
Male
Metabolic Syndrome/*blood
Middle Aged
Odds Ratio
Population Surveillance
Prospective Studies
Adiponectin
Biomarkers
Leptin
Full Text Links
  • YMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr